Linkedin Labtau  

Our Philosophy

The transfer of our research from the test bench to the bed of the patient As a pioneer in the field of therapeutic ultrasound, the laboratory values ethical respect and focuses on both Clinical and Industrial transfer, as such over the past 30 years it has developed partnerships with
Committed to a Quality Process since 2002 the LabTAU obtained its certification AFNOR ISO 9001 in 2008 and has since been working on a Quality Policy which has been reconducted with the ISO9001: 2015 Certification in 2018.

News

Thesis defense: Focused interstitial ultrasound for conformal therapy of hepatocellular carcinoma
Monday 16 December 2024

Author: Thomas Biscaldi
Time: 14H30
Language: French
Place: Conference Room at LabTAU

Abstract: Hepatocellular carcinoma is a primary tumor of the liver and is estimated to be the fourth leading cause of cancer-related death worldwide. Its incidence has been rising steadily in recent years. The gold standard of treatment is single- or multi-needle interstitial ablation, which aims to destroy the tumor locally. These strategies are proving effective, but have certain shortcomings. Interstitial treatments are not conformal: the shape... Read more

Congratulations to Thomas BISCALDI on receiving the Nadine Barrie Smith Award 2024 from the ISTU Society!
Tuesday 8 October 2024

Mr. Thomas BISCALDI, PhD student at the Laboratory of Therapeutic Applications of Ultrasound (LabTAU, French National Institute of Health and Medical Research, University Claude Bernard of Lyon, France), recently received the International Society of Therapeutic Ultrasound's (ISTU) Nadine BARRIE SMITH Award at the 23rd International Symposium for Therapeutic Ultrasound. ISTU's most prestigious student award was established in 2011 in honor... Read more

Across Acoustics: Can Sound Be Used to Diagnose Arteriosclerosis?
Tuesday 10 September 2024

Une de nos doctorante Sybille GREGOIRE est intervenue dans le podcast de l'ASA qui s'appelle Across acoustics (https://www.buzzsprout.com/1537384/15614112) pour expliquer le contenu de son article (https://pubs.aip.org/asa/jasa/article-abstract/155/5/2948/3287973/Flexural-pulse-wave-velocity-in-blood-vessels?redirectedFrom=fulltext)

Lauréats des prix de Thèse, prix jeunes chercheurs / jeunes chercheuses
Friday 5 July 2024

Lire dans le navigateur >

Lauréats du Prix de Thèse 2023 en GBM

La Société Française de Génie Biologique et Médical et l'Alliance pour le Génie Biologique et Médical, avec le soutien de la Communauté Stic-Santé, ont décerné leurs prix de thèse 2023 à l'occasion des RITS 2024 à l'Université Clermont-Auvergne.

Les quatre finalistes ont présenté leurs travaux lors... Read more

Rencontre avec Cyril LAFON : le recours aux ultrasons pour soigner le cancer du sein
Thursday 30 May 2024

La Fondation de l’Avenir a rencontré Cyril LAFON, docteur en génie biomédical, directeur de recherche en physique à l’INSERM et directeur du LabTAU1 à Lyon, pour qu’il nous présente ses travaux de recherches portant sur l’usage des ultrasons pour soigner le cancer du sein. Ce projet est mené en collaboration avec Marion CORTET, que nous avons également interviewé, notamment sur la dimension clinique en gynécologie de l’application des techniques ultrasonores développées.

L’usage des ultrasons comme traitement thérapeutique, et spécifiquement du cancer, est... Read more

previous next

Job offers

Last updated 2 December 2024

Internship
Évaluation in vitro d’une sonde ultrasonore thérapeutique pour le traitement de l’endométriose digestive
Place:
LabTAU
Release date:
Monday 2 December 2024
Response deadline:
Sunday 2 March 2025
Internship
3D Ultrasound Navigation platform for image-guided interstitial Focused Ultrasound treatment of Hepatocellular Carcinoma
Place:
LabTAU
Release date:
Friday 1 December 2023
Response deadline:
Wednesday 30 April 2025
Internship
(M2/Eng) Measurement of the acoustic impedance of a piezoelectric material with an ultrasound imaging array
Place:
LabTAU
Release date:
Friday 9 June 2023
Response deadline:
Sunday 30 June 2024